Immunofluorescent for TOMM20 and LC3B on day 16 (or 14) showed that MDS cells treated with the inhibitor showed decreased but not diminished mitophagy compared to their untreated counterparts. The gene discussed is TOMM20; the disease is myelodysplastic syndrome.